MedPath
TGA Approval

Spironolactone and Hydrochlorothiazide Tablets USP 25 mg / 25 mg Bottle (401190)

401190

Spironolactone and Hydrochlorothiazide Tablets USP 25 mg / 25 mg Bottle

Alphapharm Pty Ltd

December 18, 2022

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

hydrochlorothiazide

spironolactone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Spironolactone and Hydrochlorothiazide Tablets USP 25 mg / 25 mg Bottle (401190) - TGA 批准文号 | MedPath